Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

•Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of admission to the ICU can reduce the use of mechanical ventilation.•Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of admission to the ICU can reduce hospital length of stay and length of stay...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 2020-08, Vol.81 (2), p.318-356
Hauptverfasser: Xie, Yun, Cao, Song, Dong, Hui, Li, Qingyun, Chen, Erzhen, Zhang, Wenkai, Yang, Luyu, Fu, Shouzhi, Wang, Ruilan
Format: Artikel
Sprache:eng
Schlagworte:
Betacoronavirus
Coronavirus
Coronavirus Infections
COVID-19
Humans
Immunoglobulins, Intravenous
Letter to the Editor
Pandemics
Pneumonia, Viral
Prognosis
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of admission to the ICU can reduce the use of mechanical ventilation.•Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of admission to the ICU can reduce hospital length of stay and length of stay in ICU.•Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of admission to the ICU can reduce 28-day mortality of patients with severe COVID-19 pneumonia.
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2020.03.044